NEUROBIOLOGICAL ANNOUNCES COLLABORATIONS

Neurobiological Technologies has announced agreements with Nordmark Arzneimittel GmbH and Baxter Pharmaceutical Solutions (Baxter) to manufacture, fill and package Viprinex (ancrod) for NTI's Phase III clinical trials in acute ischemic stroke. Nordmark will manufacture the biological active ingredient, ancrod, which is derived from the venom of the Malayan pit viper (Ancistrodon rhodostoma). Key members of the Nordmark team produced the product while employed by the former Knoll AG, the previous manufacturer of ancrod.

PharmaLive (http://www.pharmalive.com/News/index.cfm?articleid=251699&categoryid=21)